Bank of New York Mellon »

Crinetics Pharmaceuticals In shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $14M 297k 46.81
2023-12-31 $12M 330k 35.58
2023-09-30 $15M 492k 29.74
2023-06-30 $8.4M 463k 18.02
2023-03-31 $6.8M 423k 16.06
2022-12-31 $6.4M 352k 18.30
2022-09-30 $6.7M 342k 19.57
2022-06-30 $6.2M 331k 18.59
2022-03-31 $6.9M 317k 21.88
2021-12-31 $9.2M 323k 28.44
2021-09-30 $6.4M 302k 21.05
2021-06-30 $5.5M 292k 18.85
2021-03-31 $4.4M 287k 15.28
2020-12-31 $3.8M 273k 14.11
2020-09-30 $2.8M 177k 15.67
2020-06-30 $3.3M 186k 17.52
2020-03-31 $528k 36k 14.66
2019-12-31 $898k 36k 25.05
2019-09-30 $520k 35k 15.01
2019-06-30 $963k 39k 24.96
2019-03-31 $593k 26k 22.82
2018-12-31 $692k 23k 29.87
2018-09-30 $454k 16k 28.72